Johnson & Johnson

Healthcare

Founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, Johnson & Johnson is a global healthcare leader delivering breakthrough pharmaceuticals and medical technologies.

View Official Johnson & Johnson Careers

Official Johnson & Johnson Careers Website

Quick Facts

Founded: 1886
Founders: Robert, James & Edward Johnson
Headquarters: New Brunswick, New Jersey
Public Ticker: NYSE: JNJ

About Johnson & Johnson

Johnson & Johnson was founded in 1886 in New Brunswick, New Jersey by brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson to manufacture ready-to-use surgical dressings.

Today, Johnson & Johnson operates worldwide across two core divisions: Innovative Medicine (oncology, immunology, neuroscience, cardiovascular) and MedTech (orthopedics, surgery, interventional solutions, vision). In 2023, J&J spun off its consumer health division into Kenvue, concentrating entirely on high-tech healthcare research and life-saving treatments.

What Johnson & Johnson Does

Innovative Medicine

Prescription therapeutics targeting complex diseases across immunology, oncology, neuroscience, and cardiology.

MedTech

Surgical robotics, orthopedic implants, cardiovascular interventions, and vision care technologies.

Robotic & Digital Surgery

Advanced robotic-assisted surgery platforms and digital healthcare analytics.

J&J Innovation (JLABS)

Global life science incubator network fostering biotech and healthcare startups.

Career Areas

Types of professional roles found inside Johnson & Johnson.

R&D & Clinical Science
Biomedical & Software Engineering
Regulatory Affairs & Quality Assurance
Global Supply Chain & Operations
Medical Affairs & Clinical Trials
Commercial & Market Access
Finance & Data Analytics
Human Resources & Legal

Johnson & Johnson's History

1886
Founded in New Jersey
Johnson brothers found J&J to produce sterile surgical products.
1944
NYSE Listing
Lists on the New York Stock Exchange under ticker symbol JNJ.
1979
Ortho Pharmaceutical Expansion
Expands therapeutics portfolio into immunology and biotech research.
2021
COVID-19 Vaccine Breakthrough
Develops single-dose Janssen COVID-19 vaccine for global emergency authorization.
2023
Kenvue Spin-Off
Spins off consumer health division Kenvue to focus 100% on Innovative Medicine and MedTech.